Showing results (171-180 of 410) with videos related to
Sort By:
Pageof 41
Journal of Cardiovascular Pharmacology|September 6, 2024
Anthocyanins in Vascular Health and Disease: Mechanisms of Action and Therapeutic PotentialYaping Zhao, Li Wang, Yu Huang, et al.BMJ Open|November 7, 2022
Current practice, attitude and views of providing pregnancy care for women with type 1 diabetes in China: a qualitative studySihui Luo, Jinhua Yan, Daizhi Yang, et al.Journal of Diabetes|April 26, 2024
Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetesYixin Gong, Tian Wei, Yujie Liu, et al.Medicine|April 9, 2016
Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled TrialQingrong Pan, Yuan Xu, Ning Yang, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 12, 2018
Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade AlbuminuriaQingrong Pan, Yuan Xu, Ning Yang, et al.Current Medical Research and Opinion|September 4, 2013
Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetesWenying Yang, Xiangjin Xu, Xiaomin Liu, et al.Journal of Diabetes|November 6, 2023
Changes in the prevalence of diabetes and control of risk factors for diabetes among Chinese adults from 2007 to 2017: An analysis of repeated national cross-sectional surveysChenye Jin, Yaxin Lai, Yongze Li, et al.Orphanet Journal of Rare Diseases|July 10, 2019
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic reviewXiaomu Kong, Lingding Xie, Haiqing Zhu, et al.Diabetes, Obesity & Metabolism|January 3, 2024
Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN trialsWenying Yang, Xiaohui Guo, Felipe Lauand, et al.Plos One|August 8, 2015
Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 DiabetesXiaomu Kong, Qi Zhao, Xiaoyan Xing, et al.Pageof 41